Advertisement

Surgical Treatment of Barrett’s Carcinoma: Correlation Between Morphologic Findings and Prognosis

  • T. Lerut
  • W. Coosemans
  • B. Dillemans
  • D. Van Raemdonck
  • P. De Leyn
  • J. M. Marnette
  • K. Geboes

Abstract

Barrett’s esophagus or columnar epithelium-lined lower esophagus is a disorder in which the normal squamous cell epithelium is replaced by a metaplastic columnar mucosa. It is estimated that it occurs in about 10% of the patients suffering from gastroesophageal reflux. The importance of Barrett’s esophagus is related to the high frequency of its association with degeneration into adenocarcinoma with a prevalence varying from 10% to 45% [1, 2]. The true risk is estimated at 30–40 times higher than within the general population [3]. As the diagnosis is frequently made in an advanced stage, the prognosis of a Barrett adenocarcinoma is reported to be poor [4]. Early diagnosis of such adenocarcinomas certainly could improve significantly the prognosis, and this opens the debate concerning surveillance programs in patients with Barrett’s metaplasia. We have been analyzing our experience with Barrett’s adenocarcinomas focusing on the results of surgical treatment and trying to establish a correlation between histomorophological findings of Barrett’s metaplasia and risk of degeneration.

Keywords

Esophageal Carcinoma Intestinal Metaplasia High Grade Dysplasia Morphologic Finding Mosaic Pattern 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG (1988) Barrett’s esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 96: 1249–1256Google Scholar
  2. 2.
    Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, Van Deventer G, Den Besten L, Rubin CE (1988) Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus without grossly recognizable neoplastic lesion. Gastroenterology 94: 81–90PubMedGoogle Scholar
  3. 3.
    Spechler SJ, Goyal RK (1986) Barrett’s esophagus. New Engl J Med 315: 361–371CrossRefGoogle Scholar
  4. 4.
    Sanfey H, Hamilton SR, Smith RRL, Cameron JL (1985) Carcinoma arising in Barrett’s esophagus. Surg Gynecol Obstet 161: 570–574PubMedGoogle Scholar
  5. 5.
    Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, Lesaffre E (1992) Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 216: 583–590PubMedCrossRefGoogle Scholar
  6. 6.
    de Meester TR, Attwood SA, Smyrk TC, Therkildsen DH, Hinder RA (1990) Surgical therapy in Barrett’s esophagus. Ann Surg 212: 528–542CrossRefGoogle Scholar
  7. 7.
    De Baecque C, Potet F, Molas G, Flejou JF, Barbier P, Martignon C (1990) Superficial adenocarcinoma of the oesophagus arising in Barrett’s mucosa with dyplasia: A clinicopathological study of 12 patients. Histopathology 16: 213–220PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • T. Lerut
  • W. Coosemans
  • B. Dillemans
  • D. Van Raemdonck
  • P. De Leyn
  • J. M. Marnette
    • 1
  • K. Geboes
    • 2
  1. 1.Department of General Thoracic SurgeryUniversity Hospitals, K.U. U.Z. GasthuisbergLeuvenBelgium
  2. 2.Department of HistopathologyUniversity Hospitals, K.U. U.Z. GasthuisbergLeuvenBelgium

Personalised recommendations